• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

积极健康干预对减轻前列腺癌幸存者症状、增强自我效能感和自我管理能力的有效性:一项随机对照试验。

Effectiveness of proactive health interventions in reducing symptoms and enhancing self-efficacy and self-management in prostate cancer survivors: a randomized controlled trial.

作者信息

Hou Sijia, Qiao Wenbo, Li Yaqin, He Huangying, Wu Bingbing, Dai Yun, Wang Wei

机构信息

Department of Nursing, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Shangcheng District, Hangzhou, 310003, Zhejiang, China.

Zhejiang University School of Medicine, Shangcheng District, Hangzhou, China.

出版信息

J Cancer Surviv. 2024 Nov 15. doi: 10.1007/s11764-024-01706-z.

DOI:10.1007/s11764-024-01706-z
PMID:39542992
Abstract

PURPOSE

To evaluate the effectiveness of a proactive health intervention in reducing symptoms, enhancing self-efficacy, and improving self-management capabilities in prostate cancer survivors.

METHODS

A single-blind randomized controlled trial was conducted with 200 prostate cancer survivors at a tertiary hospital in Zhejiang Province. Participants were randomly assigned to either the intervention group (n = 95), which received a 3-month proactive health management program based on five health modules with online and telephone follow-up, or the control group (n = 97), which received routine telephone follow-up care. Outcomes were assessed at baseline, 1 month, and 3 months post-discharge, focusing on prostate cancer symptoms, self-care ability, self-efficacy, and psychological well-being.

RESULTS

Compared to the control group, the intervention group showed significant improvements in prostate cancer symptoms (95% CI = [- 5.898, - 1.756], p < 0.001), self-care ability (95% CI = [14.427, 20.878], p < 0.001), and self-efficacy (95% CI = [0.078, 0.408], p = 0.004) after the intervention. Anxiety and depression (95% CI = [- 2.408, - 1.404], p < 0.001) were significantly reduced at the 3-month follow-up compared to baseline, although no significant difference was observed between the groups.

CONCLUSIONS

The 3-month proactive health management intervention significantly reduced symptoms, anxiety, and depression in prostate cancer survivors, while improving self-care ability and self-efficacy. Further studies with larger samples and longer follow-up periods are needed to confirm these findings.

IMPLICATIONS FOR CANCER SURVIVORS

Rehabilitation for prostate cancer survivors should integrate both physical and psychological recovery to address comprehensive health needs. Enhancing survivors' proactive health management skills supports sustained recovery.

CLINICAL TRIALS REGISTRATION

ClinicalTrial.gov Identifier: ChiCTR2300076594.

摘要

目的

评估一项积极健康干预措施在减轻前列腺癌幸存者症状、增强自我效能感以及提高自我管理能力方面的有效性。

方法

在浙江省一家三级医院对200名前列腺癌幸存者进行了一项单盲随机对照试验。参与者被随机分配到干预组(n = 95),该组接受了基于五个健康模块的为期3个月的积极健康管理计划,并进行在线和电话随访;或对照组(n = 97),该组接受常规电话随访护理。在基线、出院后1个月和3个月时评估结果,重点关注前列腺癌症状、自我护理能力、自我效能感和心理健康。

结果

与对照组相比,干预组在干预后前列腺癌症状(95%CI = [-5.898, -1.756],p < 0.001)、自我护理能力(95%CI = [14.427, 20.878],p < 0.001)和自我效能感(95%CI = [0.078, 0.408],p = 0.004)方面有显著改善。与基线相比,在3个月随访时焦虑和抑郁(95%CI = [-2.408, -1.404],p < 0.001)显著降低,尽管两组之间未观察到显著差异。

结论

为期3个月的积极健康管理干预显著减轻了前列腺癌幸存者的症状、焦虑和抑郁,同时提高了自我护理能力和自我效能感。需要进行更大样本量和更长随访期的进一步研究来证实这些发现。

对癌症幸存者的启示

前列腺癌幸存者的康复应将身体和心理恢复相结合,以满足全面的健康需求。增强幸存者的积极健康管理技能有助于持续康复。

临床试验注册

ClinicalTrial.gov标识符:ChiCTR2300076594。

相似文献

1
Effectiveness of proactive health interventions in reducing symptoms and enhancing self-efficacy and self-management in prostate cancer survivors: a randomized controlled trial.积极健康干预对减轻前列腺癌幸存者症状、增强自我效能感和自我管理能力的有效性:一项随机对照试验。
J Cancer Surviv. 2024 Nov 15. doi: 10.1007/s11764-024-01706-z.
2
An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.一项针对中风患者的扩展中风康复服务:EXTRAS RCT。
Health Technol Assess. 2020 May;24(24):1-202. doi: 10.3310/hta24240.
3
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
4
Evaluating process and effectiveness of a low-intensity CBT intervention for women with gynaecological cancer (the EPELIT Trial).评估针对妇科癌症女性的低强度认知行为疗法干预措施的过程及效果(EPELIT试验)。
AMRC Open Res. 2021 Mar 29;3:12. doi: 10.12688/amrcopenres.12971.1. eCollection 2021.
5
6
Home-based multidimensional survivorship programmes for breast cancer survivors.针对乳腺癌幸存者的居家多维康复计划。
Cochrane Database Syst Rev. 2017 Aug 24;8(8):CD011152. doi: 10.1002/14651858.CD011152.pub2.
7
Evaluating a couple-based intervention addressing sexual concerns for breast cancer survivors: study protocol for a randomized controlled trial.评估一种针对乳腺癌幸存者性问题的夫妻为基础的干预措施:一项随机对照试验的研究方案。
Trials. 2020 Feb 12;21(1):173. doi: 10.1186/s13063-019-3975-2.
8
Virtual Multidisciplinary Stroke Care Clinic for Community-Dwelling Stroke Survivors: A Randomized Controlled Trial.虚拟多学科卒中护理诊所用于社区居住的卒中幸存者:一项随机对照试验。
Stroke. 2023 Oct;54(10):2482-2490. doi: 10.1161/STROKEAHA.123.043605. Epub 2023 Aug 8.
9
Evaluation of an online intervention for improving stroke survivors' health-related quality of life: A randomised controlled trial.评价一种在线干预措施对改善脑卒中幸存者健康相关生活质量的效果:一项随机对照试验。
PLoS Med. 2022 Apr 19;19(4):e1003966. doi: 10.1371/journal.pmed.1003966. eCollection 2022 Apr.
10
Psychosocial interventions for men with prostate cancer.针对前列腺癌男性患者的心理社会干预措施。
Cochrane Database Syst Rev. 2013 Dec 24;2013(12):CD008529. doi: 10.1002/14651858.CD008529.pub3.

本文引用的文献

1
The Lancet Commission on prostate cancer: planning for the surge in cases.《柳叶刀》前列腺癌委员会:应对病例激增的规划
Lancet. 2024 Apr 27;403(10437):1683-1722. doi: 10.1016/S0140-6736(24)00651-2. Epub 2024 Apr 4.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Coping Strategies and Associated Symptom Burden Among Patients With Advanced Cancer.
晚期癌症患者的应对策略及相关症状负担。
Oncologist. 2024 Feb 2;29(2):166-175. doi: 10.1093/oncolo/oyad253.
4
Sexual satisfaction in prostate cancer: a multi-group comparison study of treated patients, patients under active surveillance, patients with negative biopsy, and controls.前列腺癌患者的性满意度:治疗患者、主动监测患者、阴性活检患者和对照组的多组比较研究。
J Cancer Surviv. 2024 Dec;18(6):1790-1798. doi: 10.1007/s11764-023-01420-2. Epub 2023 Jun 26.
5
Non-pharmacological and nonsurgical interventions in male urinary incontinence: A scoping review.男性尿失禁的非药物和非手术干预措施:范围综述。
J Clin Nurs. 2023 Sep;32(17-18):6196-6211. doi: 10.1111/jocn.16749. Epub 2023 May 9.
6
Systematic review of self-management programs for prostate cancer patients, a quality of life and self-efficacy meta-analysis.前列腺癌患者自我管理项目的系统评价:一项生活质量与自我效能的荟萃分析
Patient Educ Couns. 2023 Feb;107:107583. doi: 10.1016/j.pec.2022.107583. Epub 2022 Nov 28.
7
Analysis of the factors and moderating role of self-care ability among patients with breast cancer-related lymphedema.乳腺癌相关淋巴水肿患者自我护理能力的影响因素及调节作用分析
J Clin Nurs. 2023 Mar;32(5-6):926-940. doi: 10.1111/jocn.16495. Epub 2022 Sep 13.
8
Cancer treatment and survivorship statistics, 2022.2022 年癌症治疗和生存统计。
CA Cancer J Clin. 2022 Sep;72(5):409-436. doi: 10.3322/caac.21731. Epub 2022 Jun 23.
9
Social support, anxiety, and depression in patients with prostate cancer: complete mediation of self-efficacy.前列腺癌患者的社会支持、焦虑和抑郁:自我效能的完全中介作用。
Support Care Cancer. 2022 Aug;30(8):6851-6856. doi: 10.1007/s00520-022-07065-8. Epub 2022 May 10.
10
Feasibility, Acceptability, and Clinical Significance of a Dyadic, Web-Based, Psychosocial and Physical Activity Self-Management Program () Tailored to the Needs of Men with Prostate Cancer and Their Caregivers: A Multi-Center Randomized Pilot Trial.基于网络的心理社会和体力活动自我管理方案()用于满足前列腺癌男性及其照护者需求的可行性、可接受性和临床意义:一项多中心随机先导试验
Curr Oncol. 2022 Feb 1;29(2):785-804. doi: 10.3390/curroncol29020067.